Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapy
ConclusionsWe successfully developed modified IMDC model using a two-step process: the original IMDC plus an IG sub-stratification, and demonstrated that it predicts outcomes more accurately than original model.
Source: Japanese Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Carcinoma | Databases & Libraries | Immunotherapy | Japan Health | Kidney Cancer | Laboratory Medicine | Nephrectomy | Renal Cell Carcinoma